Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Chemotherapy
 More »

  • Pharma Touting Phase II/III Wins in Run-Up to ASCO
    ... in combination with chemotherapy in the LUME-Lung 2 trial as a second-line treatment in patients with advanced NSCLC after first-line initial chemotherapy had failed, also ...
    5-16-2013
  • FDA Approves Roche EGFR Mutation CDx for NSCLC
    erlotinib to platinum-based doublet chemotherapy in patients with metastatic NSCLC ... NSCLC after failure of at least one prior chemotherapy regimen, the agency said. ...
    5-15-2013
  • Softening the Blow from FOLFOX Treatment
    PledPharma's Modified Form of Mangafodipir Shown to Reduce Side Effects of Chemotherapy ... into a drug candidate for colorectal cancer patients undergoing chemotherapy. ...
    5-15-2013
  • Biotechs Need to Walk the Walk on Drug Value
    ... of Employees: 6 Focus: PledPharma is developing PledOx for prevention of severe chemotherapy-induced side effects. The firm is also evaluating opportunities for PLED substances ...
    5-15-2013
  • Lilly Halts Development of Lymphoma Drug After Phase III Failure
    survival in patients at high risk of DLBCL relapse following rituximab-based chemotherapy, according to a summary of topline results from PRELUDE disclosed today by Lilly. ...
    5-10-2013
  • Companion Diagnostics: 52 Pick-Up
    ... with adjuvant cyclophosphamide, doxorubicin, and 5-fluorouracil (CAF) chemotherapy. ... Herceptin (trastuzumab) and a taxane chemotherapy, for whom Kadcyla (ado-trastuzumab ...
    5-9-2013
  • The Tumor Microenvironment as a Drug Target, Part II
    ... and future FAP directed therapy may be explored in conjunction with conventional chemotherapy to augment efficacy of existing therapy against breast cancer," she said. miRNAs ...
    5-7-2013
  • Pfizer, Alberta Renew Funding for Translational Research
    to identify which cancer patients will develop a resistance to certain chemotherapy drugs. ... why women who are treated with taxane chemotherapy often develop resistance to that ...
    4-25-2013
  • Biosimilars: 10 Drugs to Watch
    ... failure; anemia in adults receiving chemotherapy to treat certain types of cancer and ... of concomitant myelosuppressive chemotherapy, and upon initiation, there is a ...
    4-22-2013
  • Aeterna Zentaris Sharing Costs, Profits for Cancer Drug
    AEZS-108 is a hybrid molecule composed of a synthetic peptide carrier and the chemotherapy ... reported for modern triple-combination chemotherapy, it was achieved with lower toxicity, ...
    4-10-2013
  • Rockland Acquires Epi-Plus Product Line
    has shown that epigenetic pharmaceuticals could be a putative replacement or adjuvant therapy for currently accepted treatment methods such as radiation and chemotherapy. ...
    4-9-2013
  • Adult Stem Cells Isolated from Human Intestinal Tissue
    or to ameliorate the side effects of chemotherapy and radiation, which often damage the ... active stem cells damaged by injury, chemotherapy, or radiation. "Now that we have been ...
    4-5-2013
  • Top 20 Best-Selling Drugs Approved and Launched During 2012
    ... leucovorin, irinotecan-(FOLFIRI) chemotherapy regimen Date of FDA approval: August ... oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS ...
    4-4-2013
  • Fighting Cancer in 3D
    Additionally, engineering tumors that mimic those in vivo offers opportunities to more accurately evaluate such strategies as chemotherapy or radiation therapies, he says. ...
    4-3-2013
  • Querying the Cancer Transcriptome
    ... The ability of cancer stem cells to evade conventional chemotherapy makes them of additional interest for therapeutic reasons. While putative cancer stem cells were identified for ...
    4-1-2013
  • More »

    Journal Articles

  • Can Subspecialty Cancer Consultations Be Delivered to Communities...
    Brian Weinerman, Johanna Den Duyf, Anne Hughes, Sarah Robertson
    Telemedicine and e-Health
    Patients and the oncologist filled out a satisfaction questionnaire. The age, sex, proportion of patients who subsequently received chemotherapy, and the number of other co-morbid ...
  • Prognostic Factors and Treatment Outcomes of 100 Cases of Anaplastic...
    Junko Akaishi, Kiminori Sugino, Wataru Kitagawa, Mitsuji Nagahama, Kaori Kameyama, Kazuo Shimizu, Kunihiko Ito, Koichi Ito
    Thyroid
    Twenty-seven patients received chemotherapy. Only 15 patients received multimodal therapy (surgery, radiotherapy, and chemotherapy). The 1-year survival rates according to stage ...
  • Disseminated Nocardia farcinica : Literature Review and Fatal...
    Jonathan M. Budzik, Mojgan Hosseini, Alexander C. Mackinnon, Jerome B. Taxy
    Surgical Infections
    A literature review revealed that disseminated N. farcinica often is associated with an underlying malignant tumor or autoimmune disease (88% of patients). Chemotherapy or ...
  • Breast Implant Infections after Surgical Reconstruction in Patients...
    Simonetta Franchelli, Francesca Vassallo, Claudia Porzio, Matilde Mannucci, Virginia Priano, Eva Schenone, Maria Stella Leone, Giuseppe Canavese, Pierluigi Santi, Andrea De Maria, Valeria Puggioni
    Surgical Infections
    infection underwent radiotherapy or chemotherapy after surgery for advanced tumors ... particularly for women who need radiotherapy or chemotherapy after implant surgery. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll